NCT04726735View on ClinicalTrials.gov

Evaluation of PD-L1 Expression and Immune Infiltration in High-risk Non Muscle Invasive Bladder Cancer

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

March 16, 2020

Primary Completion Date

May 14, 2020

Study Completion Date

May 14, 2020

Conditions
Bladder Cancer
Interventions
BIOLOGICAL

Samples of bladder tissue

Samples of bladder tissue collected between 2007 and 2011.

Trial Locations (1)

Unknown

Centre Hospitalier Universitaire de Bordeaux, Talence

All Listed Sponsors
collaborator

University of Bordeaux

OTHER

lead

University Hospital, Bordeaux

OTHER

NCT04726735 - Evaluation of PD-L1 Expression and Immune Infiltration in High-risk Non Muscle Invasive Bladder Cancer | Biotech Hunter | Biotech Hunter